Recommendations for the management of acute immune thrombocytopenia in children. A Consensus Conference from the Italian Association of Pediatric Hematology and Oncology.
Blood transfusion · 01.05.2024 · 22 (3) · 253-265
DOI: 10.2450/bloodtransfus.501 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood transfusion, erschienen am 01.05.2024. Verfasst von Giovanna Russo und 23 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Onco-hematology Unit, Azienda Policlinico Rodolico San Marco, Department of Clinical and Experimental Medicine, University of Catania, Ital…. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic. Die Arbeit wurde bisher 21-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
BACKGROUND: Immune thrombocytopenia (ITP) is an acquired immune-mediated bleeding disorder characterized by isolated thrombocytopenia. Its estimated yearly incidence in the pediatric population is 1.9-6.4/100,000. ITP in children is usually a self-limiting and benign disorder. The clinical management of children with ITP often remains controversial, as robust randomized trials on the management of this disorder are lacking. Treatments vary widely in clinical practice and existing guidelines from hematology societies on clinical management offer indications based largely on expert opinion rather than strong evidence. MATERIALS AND METHODS: The Coagulative Disorder Working Group of the Italian Association of Pediatric Hematology and Oncology (AIEOP) developed this document to collect shared expert opinions on the management of newly diagnosed ITP, updating previous guidelines and providing recommendations to pediatricians. Each statement has been given a score expressing the strength of evidence, appropriateness and agreement among participants. RESULTS: Clear-cut definitions of the clinical phases of the disease and clinical response are stated. Recommendations are given regarding the classification of bleeding symptoms, evaluation of bleeding risk, diagnosis, and prognostic factors. Specific recommendations for treatment include indications for first-line (intravenous immunoglobulins, steroids) and second-line (combined therapy, thrombopoietin receptor agonists, immunosuppressive drugs, rituximab) therapeutic agents, as well as hemorrhagic emergency and supportive treatment, including emergency splenectomy. The optimal follow-up schedule, the relation between ITP and vaccines and health-related quality-of-life issues are also discussed. DISCUSSION: The panel achieved broad consensus on issues related to how to treat children with newly diagnosed ITP, providing a comprehensive review of all relevant clinical aspects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pediatric Onco-hematology Unit, Azienda Policlinico Rodolico San Marco, Department of Clinical and Experimental Medicine, University of Catania, Italy.
- Pediatric and Neonatology Unit, Ordine Mauriziano Hospital, Turin, Italy.
- Pediatric Hematology and Oncology Unit, ARNAS Ospedale Civico, Palermo, Italy.
- Direzione Medica di Presidio, Children's Hospital, ASST-Spedali Civili, Brescia, Italy.
- Department of Women, Children and General and Specialized Surgery, "Luigi Vanvitelli" Università degli Studi della Campania, Naples, Italy.
- Pediatric Hematology Oncology, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Zitieren
APA
Russo, G., Parodi, E., Farruggia, P., Notarangelo, L. D., Perrotta, S., Casale, M., Cesaro, S., Del Borrello, G., Del Vecchio, G. C., Giona, F., Gorio, C., Ladogana, S., Lassandro, G., Marzollo, A., Maslak, K., Miano, M., Nardi, M., Palumbo, G., Rossi, F., …, & Giordano, P. (2024). Recommendations for the management of acute immune thrombocytopenia in children. A Consensus Conference from the Italian Association of Pediatric Hematology and Oncology. Blood transfusion, 22(3), 253-265. https://doi.org/10.2450/bloodtransfus.501
Vancouver
Russo G, Parodi E, Farruggia P, Notarangelo LD, Perrotta S, Casale M, et al. Recommendations for the management of acute immune thrombocytopenia in children. A Consensus Conference from the Italian Association of Pediatric Hematology and Oncology. Blood transfusion. 2024;22(3):253-265. doi:10.2450/bloodtransfus.501
BibTeX
@article{Russo2024,
author = {Russo, Giovanna and Parodi, Emilia and Farruggia, Piero and Notarangelo, Lucia D and Perrotta, Silverio and Casale, Maddalena and Cesaro, Simone and Del Borrello, Giovanni and Del Vecchio, Giovanni C and Giona, Fiorina and Gorio, Chiara and Ladogana, Saverio and Lassandro, Giuseppe and Marzollo, Antonio and Maslak, Karolina and Miano, Maurizio and Nardi, Margherita and Palumbo, Giuseppe and Rossi, Francesca and Spinelli, Marco and Tolva, Alessandra and Saracco, Paola and Ramenghi, Ugo and Giordano, Paola},
title = {Recommendations for the management of acute immune thrombocytopenia in children. A Consensus Conference from the Italian Association of Pediatric Hematology and Oncology},
journal = {Blood transfusion},
year = {2024},
volume = {22},
number = {3},
pages = {253--265},
doi = {10.2450/bloodtransfus.501}
}
EUVIMED